loadpatents
name:-0.01509690284729
name:-0.0084469318389893
name:-0.0011930465698242
Bergauer; Markus Patent Filings

Bergauer; Markus

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bergauer; Markus.The latest application filed is for "fused tricyclic derivatives for the treatment of psychotic disorders".

Company Profile
0.8.13
  • Bergauer; Markus - Verona IT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds
Grant 8,153,623 - Alvaro , et al. April 10, 2
2012-04-10
Method of treating epilepsy by administering 5-(4{[(2-fluorophenyl)methyl]oxy}phenyl)prolinamide
Grant 8,153,681 - Alvaro , et al. April 10, 2
2012-04-10
Methods of treating bipolar disorders
Grant 8,143,306 - Alvaro , et al. March 27, 2
2012-03-27
Fused Tricyclic Derivatives For The Treatment Of Psychotic Disorders
App 20120022056 - Bentley; Jonathan ;   et al.
2012-01-26
Novel Compounds
App 20110098335 - Alvaro; Giuseppe ;   et al.
2011-04-28
Novel Compounds
App 20100324022 - Alvaro; Giuseppe ;   et al.
2010-12-23
Compounds
Grant 7,855,218 - Alvaro , et al. December 21, 2
2010-12-21
Compounds
Grant 7,803,833 - Alvaro , et al. September 28, 2
2010-09-28
Quinoline and Quinazoline Derivatives Having Affinity for 5HT1-Type Receptors
App 20100204273 - Bergauer; Markus ;   et al.
2010-08-12
Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
Grant 7,732,600 - Bergauer , et al. June 8, 2
2010-06-08
Prolinamide Derivatives As Modulators Of Voltage-gated Sodium Channels
App 20100130583 - Alvaro; Giuseppe ;   et al.
2010-05-27
5-(4phenyl)prolinamide For Treatment Of Epilepsy
App 20100105754 - Alvaro; Giuseppe ;   et al.
2010-04-29
Compounds
Grant 7,655,693 - Alvaro , et al. February 2, 2
2010-02-02
Quinoline And Quinazoline Derivatives Having Affinity For 5ht1-type Receptors
App 20090312546 - BERGAUER; Markus ;   et al.
2009-12-17
Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
Grant 7,592,346 - Bergauer , et al. September 22, 2
2009-09-22
Novel Compounds
App 20080306122 - Alvaro; Giuseppe ;   et al.
2008-12-11
Novel Compounds
App 20080293753 - Alvaro; Giuseppe ;   et al.
2008-11-27
Quinoline And Quinazoline Derivatives Having Affinity For 5ht1-type Receptors
App 20080280919 - Bergauer; Markus ;   et al.
2008-11-13
Novel Compounds
App 20080280969 - Alvaro; Giuseppe ;   et al.
2008-11-13
Quinoline And Quinazoline Derivatives Having Affinity For 5ht1-type Receptors
App 20070167423 - Bergauer; Markus ;   et al.
2007-07-19
Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
App 20060229312 - Bergauer; Markus ;   et al.
2006-10-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed